Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


The UAB heads a European research project on proteases and pathological processes

A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Avilés, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations.

Entitled "Chemical Genomics by Activity Monitoring of Proteases" (CAMP), the project was designed with the final objective of developing drugs to control proteases in inflammations, cardiovascular diseases, cancer and neurodegeneration.

The project has already begun and is being carried out by a consortium of research groups from different universities, small and medium sized enterprises, and a large pharmaceutical company. Although under UAB coordination, six other collaborating centres from Germany, Switzerland, Slovenia, United Kingdom and Denmark also work on the project. CAMP forms part of the European Union's Specific Targeted Catering Projects (STREP) and has a duration of three years.

Proteases are enzymes, or proteins that act as catalysts for other proteins when regulating many of the biological processes involved in blood coagulation, food processing, extracellular matrix renewing, etc. Without the regulation of protease activity, numerous pathologies can appear, such as cardiovascular, neuron and autoimmune diseases, inflammations, osteoporosis, arthritis and cancer.

... more about:
»UAB »cAMP »pathological »processes

The main objective of the CAMP project is to obtain information on the structure, activity and evolution of the proteases and its inhibitors (molecules that alter their functions) by monitoring their activities in situ and in vivo.

This will then help discover where the proteases that the drugs need to act on can be found. With this aim, the researchers have developed substrates with fluorescent molecules that will be attached to the proteases. This will allow them to monitor the proteases in tissue culture and live animals. The information obtained will then enable scientists to develop specific protease inhibitors.

Octavi López Coronado | alfa
Further information:

Further reports about: UAB cAMP pathological processes

More articles from Life Sciences:

nachricht ‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie

nachricht Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Oasis of life in the ice-covered central Arctic

24.10.2016 | Earth Sciences

‘Farming’ bacteria to boost growth in the oceans

24.10.2016 | Life Sciences

Light-driven atomic rotations excite magnetic waves

24.10.2016 | Physics and Astronomy

More VideoLinks >>>